MYLAN INC | 24,286 Euro | +0,036 +0,15 % | |
| WKN: 868270 ISIN: US6285301072 Ticker-Symbol: MYL | Frankfurt | 17.05.13 | 16:29 Uhr |
Branche PharmaAktienmarkt NASDAQ-100S&P 500 NASDAQ Biotech |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 17.05. | Mylan's Generic Version Of Tricor Tablets For Cholesterol Gets FDA Approval | 137 | AFX News | |
| CANONSBURG (dpa-AFX) - Generic drug maker Mylan Inc. (MYL), Friday said its
unit Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and
Drug Administration for its Abbreviated... Mehr lesen zu: Mylan's Generic Version Of Tricor Tablets For Cholesterol Gets FDA Approval | ||||
| 17.05. | Mylan (MYL) Launches Generic Tricor Tabs (ABBV) | - | StreetInsider.com | |
| 17.05. | Mylan Launches Generic Tricor Tablets | 61 | PR Newswire | |
| PITTSBURGH, May 17, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg. Mylan Pharmaceuticals... Mehr lesen zu: Mylan Launches Generic Tricor Tablets | ||||
| 16.05. | Recent 52-Week High Exceeded in Shares of Mylan | 3 | SmarTrend | |
| 16.05. | FDA approves Mylan Zolmitriptan ANDA | 2 | Pharma Bus Review | |
| 15.05. | Mylan: Solid Results Despite Revenue Miss | - | Seeking Alpha | |
| 15.05. | Mylan Launches Generic Zomig Tablets | 58 | AFX News | |
| CANONSBURG (dpa-AFX) - Generic drugmaker Mylan Inc. (MYL) said Wednesday
that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from
the U.S. Food and Drug Administration... Mehr lesen zu: Mylan Launches Generic Zomig Tablets | ||||
| 15.05. | Mylan (MYL) Unit Launches Generic Zomig Tabs | - | StreetInsider.com | |
| 15.05. | Mylan Launches Generic Zomig Tablets | 37 | PR Newswire | |
| PITTSBURGH, May 15,2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug... Mehr lesen zu: Mylan Launches Generic Zomig Tablets | ||||
| 15.05. | Kreise: Actavis zeigt Generikahersteller Mylan die kalte Schulter | 207 | dpa-AFX | |
| Der Generikahersteller Actavis
hat nach Informationen aus Kreisen ein Übernahmeangebot seines
US-Konkurrenten Mylan ausgeschlagen. Mylan habe
für den größeren Konkurrenten in der vergangenen... Mehr lesen zu: Kreise: Actavis zeigt Generikahersteller Mylan die kalte Schulter | ||||
| 15.05. | Reports: Actavis Spurns $15 Bln Bid From Mylan To Pursue Warner Chilcott Deal | 126 | AFX News | |
| CANONSBURG (dpa-AFX) - Generic drug maker Actavis, Inc., which acquired
Watson Pharmaceuticals, Inc., is said to have spurned a $15 billion cash and
stock acquisition offer from rival Mylan... Mehr lesen zu: Reports: Actavis Spurns $15 Bln Bid From Mylan To Pursue Warner Chilcott Deal | ||||
| 15.05. | Actavis rejected $15 billion offer from Mylan - source | 3 | Reuters.com | |
| 15.05. | Actavis rejected $15 billion offer from Mylan: source | - | Reuters.com | |
| 14.05. | Report: Mylan offered $15B for generic drugmaker | 1 | bizjournals | |
| 14.05. | Actavis Said to Have Spurned $15 Billion Offer From Mylan | 3 | Bloomberg | |
| 10.05. | Presenting Sponsor Mylan Specialty L.P. Calls on Communities Nationwide to Join The Food Allergy Research & Education (FARE) Walk for Food Allergy | 63 | PR Newswire | |
| BASKING RIDGE, N.J., May 10, 2013 /PRNewswire/ -- In recognition of Food Allergy Awareness Week, Mylan Specialty L.P., the fully integrated specialty pharmaceutical business of Mylan Inc. (NASDAQ:... Mehr lesen zu: Presenting Sponsor Mylan Specialty L.P. Calls on Communities Nationwide to Join The Food Allergy Research & Education (FARE) Walk for Food Allergy | ||||
| 03.05. | Mylan Management Discusses Q1 2013 Results - Earnings Call Transcript | 3 | Seeking Alpha | |
| 03.05. | ROUNDUP: Mylan Q1 Profit Declines | 71 | AFX News | |
| CANONSBURG (dpa-AFX) - Generic drug maker Mylan Inc. (MYL), Thursday
reported a decline in profit for the first quarter, hurt mainly by acquisition
related costs and licensing payments.... Mehr lesen zu: ROUNDUP: Mylan Q1 Profit Declines | ||||
| 02.05. | BRIEF-Mylan sees Q2 adjusted EPS $0.66-$0.68 | 1 | Reuters.com | |
| 02.05. | UPDATE 1-Mylan first-quarter profit edges past Wall St estimates | 1 | Reuters.com | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| STADA ARZNEIMITTEL | 33,555 | -0,93 % | STADA: Gute Zahlen und positive Analystenstimmen beflügeln Kurs |
| PFIZER | 22,565 | -1,03 % | Global Vision Selected by Pfizer for Worldwide Deployment of Automated Proofreading Solutions |
| SANOFI | 84,54 | -0,06 % | Berenberg hebt Ziel für Sanofi auf 93 Euro - 'Hold' |
| NOVARTIS | 57,46 | -1,61 % | Gericht prüft Klage von Pharmakonzern Novartis gegen Bewertung |
| TEVA PHARMACEUTICAL INDUSTRIES | 31,55 | +1,77 % | XETR DIVIDEND INFORMATION - 16.05.2013 - 1 |
